NCT04134260
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04134260
Title Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors NRG Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.